Emcure Pharmaceuticals to expand gynaecology, derma portfolio for India market in FY26 administrator admin Date 22 May, 2025 Share: Prev Emcure Pharmaceuticals Q4 Results: Profit surges 63% YoY on strong domestic and international growth Emcure stake buy: Pharma firm to acquire 20.42% in Zuventus for Rs 724.9 crore; full ownership to aid consolidation Next
